Dr ko 3bp

Pedersen at Johns Hopkins University sometime around 2002. Ko over use patent for cancer treatment to make. A. Ko, Peter L. med. Young Ko who seemingly discovered a back door way to attack the majority of cancer cells metabolically through the use of a chemical 3-BP (3  as a potent and specific anticancer agent, published in 2001 (Ko et al. The molecule mimics the chemical structure of lactic acid except that it's very reactive. As it happens, I'm currently in discussion with Ko to see if we can make this therapy available to the public. Contact Name: Young Hee Ko, Ph. 12 Aug 2016 3BP, part of a class of compounds known as small molecule drugs, was first studied as an anti-cancer agent more than a decade ago at Johns Hopkins by biochemists Young Hee Ko and Peter Pedersen, together with radiologist Jeff Geschwind. Include is the story of Dr. Aug. It's called 3-bromo-pyruvate: “The pyruvate mimetic 3-bromopyruvate (3-BP) is generally presented as  19 Feb 2016 3-Bromopyruvate (3BP) has been shown to primarily target HKII, and is a promising anti-cancer compound capable of altering critical metabolic pathways in cancer cells. Prof. Ko. 3BP and similar compounds safe for use. It's called 3-bromo-pyruvate: “The pyruvate mimetic 3-bromopyruvate (3-BP) is generally presented as  Apr 16, 2017 Dr. Prepublication paper June 6, 2014 Paweł Lis, Young H. Ko's work was heralded in an article in the Baltimore Sun and dozens of cancer patients contacted the medical center to inquire when  2 Jun 2016 Johns Hopkins Peter Pedersen and Young Ko found a better way fifteen years ago. com. D. . 9 Jan 2015 (3,4) Above left image, Cover of book Cancer as a Metabolic Disease by Dr Thomas Seyfried courtesy of the Examiner. Please visit www. • Dr. Ko while working in the lab of Prof. 5 mg/kg body weight) reported recently by Ko et al. Dr. , 3-bromopyruvate (3BP), met the two criteria noted above. Ko associated  29 Sep 2014 The cancer-fighting properties of 3-BrPA have been recognized since 2004, when Dr. Ko did find a compound that inhibits HK2. These cancer cells have a cellular metabolism that can be attacked by a small molecule such as 3-BP. Be very  15 Dec 2016 In addition, properly formulated 3BP shows promise also as an effective anti-liver cancer agent in humans and is effective also toward cancers known as “multiple Paweł Lis 1, Mariusz Dyląg 1, Katarzyna Niedźwiecka 1, Young H. Pedersen and Ko felt  Free Online Library: War on cancer: 3BP and the metabolic approach to cancer: a visit with Peter Pedersen and Young Hee Ko. Young Ko, at Washington University for her biochemistry doctorate worked with 3-bromopyruvate (3bp), extremely reactive molecule that mirrors lactic acid. 2016 Pederson und Ko arbeiteten seit 1991 gemeinsam an der Johns Hopkins School of Medicine in Baltimore (USA). singlecausesinglecure. Like other  22 Mar 2016 Dr. Young Ko who seemingly discovered a back door way to attack the majority of cancer cells metabolically through the use of a chemical 3-BP (3 . Basic science studies by Drs Ko and Pederson have uncovered the exact details of the metabolic reprogramming of the mitochondria of  Aug 10, 2016 Dr. Email: kocancer212@yahoo. But for all the talk we've lost  Unfortunately, nobody knew just how costly it had been—not his father, not his doctors, not Dr. Young-Hee Ko. Ko has founded a small start-up company, *KoDiscovery, LLC, in Baltimore, Maryland to further develop 3BP as a potent anticancer drug option for cancer patients who have run out of all available treatment options or those patients who wish to be treated with 3BP as the first therapy. Martin G. L. It's a very . Young Hee. 2. So much of his liver had In the summer of 2009, with Yvar's trial nearing its completion and four years after the Baltimore Sun article, word about the blockbuster potential of 3BP found its way to the top. S. Pedersen 3, Andre Goffeau 4 and Stanisław Ułaszewski 1,*. Drs Ko and Pederson, 3BP and Hexokinase II. Young Ko via a project led J. The molecule mimics the chemical structure of lactic acid except that it's very reactive. Ko, forced out of Johns Hopkins by not giving her lab space; so, she couldn't get grants. Drs Ko and Pederson discovered a small molecule called 3BP which throws a "monkey wrench" into the metabolic machinery of the cancer cell, and induces apoptosis via separation of Hexokinase II from the outer mitochondrial membrane. Upon review it appears that 3BP was discoverd by Dr Young Ko at John Hopkins and apparently patented. Peter Pedersen is a professor of biological chemistry and oncology at the Johns Hopkins University School of Medicin Dyląg M, Lis P, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S. Thomas J. , Pomper M. by "Townsend Letter"; Health, general Antimitotic agents Research Antineoplastic agents Cancer Care and treatment Physiological aspects Cancer treatment Medical research personnel Services  A research/discovery company committed to applying their scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and neuro-degenerative diseases. Upon further study, I find that the drug is currently under phase I FDA approved clinical trial by a biotech company called Prescience Labs who claims to have the drug patented. This is an official announcement that all AUTHENTIC Dr. A patent rights dispute between Dr. - Dr. Ko discovered that 3BP (actually it is 3-BrPa or 3 – bromopyruvic acid) was cancer's Achilles heel/heal in that it mimicked lactic acid and therefore migrated across the cancer cell's otherwise impenetrable cell wall to cause localized hypoglycemia. [3] Ko, Y. Peter L. (Ko et al. Treatment Being Blocked for Use. showed that only one, i. Ko and her pink-eyed rats, named "One Dottie" and "July Mom" (JM), are late for a date in Dr. Meanwhile, enter Dr Ko, who has found a game-changing way to exploit this discovery. CEO 801 W. org/ · Bromopyruvic acid - Wikipedia, the free encyclopedia · War on cancer: 3BP and the metabolic approach to cancer: a visit with Peter Pedersen and Young Hee Ko. • Conflict between Johns Hopkins and Dr. , Rini D. "3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus  30 Aug 2017 I have been reading the book "Tripping over the truth" - basically a background on cancer research and the Warburg effect. Pedersen*, Andre Goffeau and  6 Jun 2016 (Pedersen also wanted me to flag that the critical research on 3-bromopyruvate was carried out by Dr. 30 Aug 2013 - 15 min - Uploaded by Harrie VerhoevenYvar's presentation about his illness (HCC) and treatment with bromopyruvate. Suite 502 E&F. 2001). Ko and Petersen there will no fortune (but hopefully a Noble Prize) only the satisfaction of knowing that they can save untold lives. I have pledged some money and I am trying to encourage others to crowd source (GoFundMe. Pomper's radiology lab,  30 Sep 2014 He chastised the cancer industry for ignoring an off-the-shelf molecule initially produced in the 1940s called 3-bromopyruvate (3-BP) that had been found to In 2005 Dr. , Torbenson M. Ko at JHU“, and, of course, the ever popular “Is a Cancer Cure Being Suppressed?” In each case, as happened for DCA, it's insinuated (or outright claimed) that 3-BP is a drug  Aug 12, 2016 3BP, part of a class of compounds known as small molecule drugs, was first studied as an anti-cancer agent more than a decade ago at Johns Hopkins by biochemists Young Hee Ko and Peter Pedersen, together with radiologist Jeff Geschwind. Pedersen's lab. drkoskincare. Her idea was that the cancer cell would mistake 3-BP for lactic acid. Aug 11, 2015 The anti-cancer potential of 3BP has been demonstrated by Dr. Geschwind who at that time was working at Johns Hopkins University as well, publish his own patents  Yvar Verhoeven was the first person in a small group of patients with different kinds of cancer to be treated with Dr. koskinspecialist. koskinspecialist. Peter Pedersen's lab at Johns Hopkins in Baltimore Maryland has thoroughly investigated 3-BP and then a formulation for 3-BP has been worked out to increase  Aug 15, 2016 The “alternative” cancer cure press has been publishing articles with titles like “ Cancer Cured, Again“, “Cancer Cure Found by Dr. Here is a link to Prof. Ko at JHU“, and, of course, the ever popular “Is a Cancer Cure Being Suppressed?” In each case, as happened for DCA, it's insinuated (or outright claimed) that 3-BP is a drug  Bromopyruvic acid is the organic compound with the formula BrCH2COCO2H. Ko actually tried 3-BP on every human cancer cell line that is available and saw very positive results, all cancer cells seem to metabolize in much the same way. (2004) Advanced cancers: eradication in all cases using  1 Apr 2016 3BP is a chemical that can be purchased from any chemical supply company over the counter and it is not expensive. Young Hee Ko's patented formulation of 3- bromopyruvate (3-BrPA). Later YHK would lead a team of investigators in an effort to . This a colorless solid is the brominated derivative of pyruvic acid. Later, when at Johns Hopkins University, she noticed, from failed cellular mitochondrial, that cancer cells over produce lactic acid from anaerobic  Aug 30, 2013 Yvar's presentation about his illness (HCC) and treatment with bromopyruvate. When working for her doctorate she studied 3-BP. In melanoma, the most deadly skin cancer, 3BP induced necrotic cell death in sensitive cells, whereas high glutathione (GSH) content made other melanoma cells resistant to 3BP. Shannon Kesl  Most recently, a transition state structure (Publication 157) in the presence of vanadate has been obtained with crystals prepared by Dr. Young Ko discovered that the small molecule 3-bromopyruvate (3BP) is a potent anticancer agent. Ko Skin Care (Dermax, Ko Series, Ko Dermaceutical, Ko Dermacare & eKo) are only available at Ko Skin Specialist Centre, all Dr. Peter Pedersen from Johns Hopkins for a pharmacokinetic study on 3-BP, a promising drug that stops the cancer energy source. Dwight. Pedersen, Ph. Bromopyruvic acid is the organic compound with the formula BrCH2COCO2H. Basic science studies by Drs Ko and Pederson have uncovered the exact details of the metabolic reprogramming of the mitochondria of  8 Jan 2005 Down stairwells, through automatic doors and across glassed-in bridges spanning busy East Baltimore streets, she is a blur of black clogs, blue jeans and obligatory white lab coat. My best strategy to make it widely available is to have Cancer Treatment Centers of America (CTCA), who initially refused her request to  6 Aug 2016 This led to the discovery in an experiment conceived, designed, and conducted by Young Ko that the small molecule 3-bromopyruvate (3BP), the subject of this mini-review series, is an incredibly powerful and swift acting anticancer agent. Based on the reference 3BP dosage range in humans (2–3. 19 Jan 2017 Dr. Pedersen's lab. Since this is something that the larger pharmaceutical companies are not interested in funding (3BP can be  8 Nov 2013 http://www. Like other  Oct 13, 2016 Apparently Effective 3 BP. Baltimore Street. 3BP (3 Bromo Pyruvate) is  Initially produced in the 1940s, an off-the-shelf molecule called 3-bromopyruvate (3-BP) had been all but forgotten until it came to the attention of Young Hee Ko, Ph. - Free Online Library · Dr. Ko clinics and www. , Hullihen J. CEO. Young Ko. He was the first person to have treatment by TACE with 3-bromopyruvate, a promising agent against primary liver cancer (HCC). Ko wondered whether this difference between a normal cell and a cancer cell could be exploited. Ko's protocol is what makes 3BP effective. Ko 2, Peter L. Young Hee Ko's patented formulation of 3-bromopyruvate (3-BrPA). Several years later while working as a new faculty member in collaboration with my laboratory she would lead a team that showed 3BP's capacity to  3-Bromopyruvate (3—BP): We gave a $25,000 grant to Dr. com for the full list of Dr Ko's clinics and their locations. e. Later, when at Johns Hopkins University, she noticed, from failed cellular mitochondrial, that cancer cells over produce lactic acid from anaerobic  2 Oct 2014 He chastised the cancer industry for ignoring an off-the-shelf molecule initially produced in the 1940s called 3-bromopyruvate (3-BP) that had been found to In 2005 Dr. , Pedersen P. 30 Oct 2009 Biochem Biophys Res Commun 2004;324(1):269-75] is the use of the small molecule 3-bromopyruvate (3-BP) that selectively enters and destroys the . It is believed to “starve” tumor cells to death by inhibiting  A research/discovery company committed to applying their scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and neuro-degenerative diseases. 14 Jan 2015 Discovery of 3BP by Dr. Baltimore Street, Suite 502-E&F Baltimore, MD 21201. It was administered intra-arterially by Univ. ( Schijndel, the Netherlands) for photography and his expertise as a nurse, Dr. Ko, forced out of Johns Hopkins by not giving her lab space; so, she couldn't get grants. Significantly, in subsequent experiments with rodents (19 animals  16 Apr 2017 Dr. "3 -Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus  as a potent and specific anticancer agent, published in 2001 (Ko et al. Young Ko of University of Maryland and. , Smith B. from Washington, called 3-bromopyruvate (3bp). Die Untersuchungen von Ko waren 2005 Gegenstand von Berichten der regionalen Presse und  2 Jan 2015 The scientist who dedicated herself to this and did the bulk of the work on it (at the expense of her personal life, according to the book) is Dr. Baltimore Maryland 21201. Peter Pedersen's lab at Johns Hopkins in Baltimore Maryland has thoroughly investigated 3-BP and then a formulation for 3-BP has been worked  11 Aug 2015 The anti-cancer potential of 3BP has been demonstrated by Dr. His son ended up living a year longer, with almost complete recovery but died because of an infection, not because of cancer. H. Abnormal vasculature within tumours leads to heterogeneous microenvironments, including glucose availability, which may affect drug  28 Dec 2014 Young Hee Ko, Ph. Unlike all other chemotherapy drugs, 3-BP does not hurt the host human or animals. , a medical researcher at Johns Hopkins. Together with the anion bromopyruvate, BPA is lactic acid and pyruvate analogs. I see no referrence to Dr. com for the full list of Dr Ko's clinics and their locations. Ko has a study approved in Poland with 12 patients and only needs $$$ to complete the clinical trial. Young Ko has shown already that several human breast cancer cell lines are killed by 3-BrPA, and in future studies she will examine the effect of  making available the product 3-Bromopyruvate (3-BP) to patients with all types of cancer, not just liver cancer. Use your millions to bring a cure to all patients, It has bee tested and proven effective by hundreds of scientists around the world in all preclinical systems and even humans on humane basis. Peter Pedersen Explaining the Promise of 3-BP | Single Cause, Single Cure  8 Feb 2016 She remembered this compound she had worked with while getting her Ph. Other biguanides (hypoglycemia-inducing drugs) are  But 3-BP works on all PET scan positive cancer cells. He was the first SPECIAL NOTE FROM DR. It has been investigated as a metabolic poison and an anticancer agent. , Wang Y. Address: 801 W. Ko Skin Care (Dermax, Ko Series, Ko Dermaceutical, Ko Dermacare & eKo) are only available at Ko Skin Specialist Centre, all Dr. 13 Oct 2016 Apparently Effective 3 BP. Dayspring has an by a small molecule such as 3-BP. ) Apparently Dr. Geschwind who at that time was working at Johns Hopkins University as well, publish his own patents  3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a This led to the discovery in an experiment conceived, designed, and conducted by Young Ko that the small molecule 3-bromopyruvate (3BP), the subject of  Yvar Verhoeven was the first person in a small group of patients with different kinds of cancer to be treated with Dr. While working on the history portion of my article, I received extremely valuable assistance from Petra Gentz-Werner, who has written several books about  Mar 22, 2016 Dr. Tel: 202-621-0227. Ko's work was heralded in an article in the Baltimore Sun and dozens of cancer patients contacted the medical center to inquire when  While working in my laboratory at the beginning of this century Dr. For Drs. Suite 502 E&F. Helped guide experiments of Young Ko and collaborators where she independently discovered that the simple alkylating agent 3-bromopyruvate (3BP) is a  Peter L. (Schijndel, the Netherlands) for photography and his expertise as a nurse, Dr. Young Ko published a journal article describing how the compound eradicated cancer in all of her study animals. G. I didn't read the whole thread but the last pages make mention of some scams where Dr Ko's name and references to her work were made to sucker people in. "Dr. Vogl, Direktor, Institut für Diagnostische und  Jan 9, 2015 (3,4) Above left image, Cover of book Cancer as a Metabolic Disease by Dr Thomas Seyfried courtesy of the Examiner. Aug 30, 2017 I have been reading the book "Tripping over the truth" - basically a background on cancer research and the Warburg effect. He was invited by Prof Pedersen and Dr Ko, the people involved in the discovery of this new drug,  This is an official announcement that all AUTHENTIC Dr. ) More on Otto Warburg and the Nazis. Peter Pedersen's lab at Johns Hopkins in Baltimore . War on cancer: 3BP and the metabolic approach to cancer: a visit with Peter Pedersen and Young Hee Ko. It is believed to “starve” tumor cells to death by inhibiting  15 Aug 2016 The “alternative” cancer cure press has been publishing articles with titles like “Cancer Cured, Again“, “Cancer Cure Found by Dr. Jan 2, 2015 The scientist who dedicated herself to this and did the bulk of the work on it (at the expense of her personal life, according to the book) is Dr. . (7)(27, 28). Peter Pedersen of Johns Hopkins University in the realm of the drug 3BP (3-Bromopyruvate) is potentially of major value here. They discovered that the 3BP molecule when added to cancer cells can inhibit both glycolysis and  7 Feb 2016 Efforts Underway to Bring 3BP Into Cancer Treatment Centers. Vogl, Direktor, Institut für Diagnostische und  10 Aug 2016 Dr. Ko discovered that 3BP (actually it is 3-BrPa or 3 – bromopyruvic acid) was cancer's Achilles heel/heal in that it mimicked lactic acid and therefore migrated across the cancer cell's otherwise impenetrable cell wall to cause localized hypoglycemia. 2001 veröffentlichte Ko über einen möglichen Einsatz von 3-BP bei der Bekämpfung von Krebs. 7 Feb 2014 Recent work in breast cancer cells showed that MCTs may be involved in the uptake of 3-bromopyruvate (3BP) [2], a potent anti-tumor agent. Ko and Johns Hopkins University stalled further development of the  3 Mar 2015 The work of Young Hee Ko, PhD (former Johns Hopkins researcher) and Dr. Trojan horse sneaks inside  6. com) the rest. Other biguanides (hypoglycemia-inducing drugs) are  6 Dec 2017 But 3-BP works on all PET scan positive cancer cells